Balanced infusion solution

LAP366AUndetermined Publication Date: 2026-01-09ECOPHARM PATENT MANAGEMENT
0 Cites 0 Cited by

Patent Information

Application Number
LAP366
Authority / Receiving Office
LA · LA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2014-05-20
Filing Date
2015-05-18
Publication Date
2026-01-09
Patent Text Reader

Abstract

The invention is related to medicine and pharmacology, in particular, to salt infusion solutions having detoxicating effect, and may be used for treatment of diseases and conditions associated with organism intoxications of various severity degrees. The objective of the invention is to provide a novel, balanced infusion solution having higher detoxicating activity, low toxicity and ensuring a broad area of clinical application. The above-stated objective is attained by provision of a balanced infusion solution containing sodium, potassium and magnesium chlorides, a solvent and a biologically active ingredient, which, in accordance with the invention, includes sodium L-arginine succinate of the formula: Na+[NH=C(NH)2NH(CN2)3CH(NH2)COOH]+[OOC(CH2)2COO]2- As the biologically active ingredient, proportion of the components being as follows (% by mass): Sodium chloride 0.540-0.600 Magnesium chloride hexahydrate 0.015-0.030 Potassium chloride 0.025-0.040 Sodium L-arginine succinate 1.400-1.700 Water of injections the balance.
Need to check novelty before this filing date? Find Prior Art